Table 4 Treatment-related adverse events in the reviewed studies
Study name | Intervention group (Sample size) | Type of adverse events | Control group (Sample size) | Type of adverse events |
|---|---|---|---|---|
Grecco et al.,2015 | 10 | Mild tingling (N = 4) | 10 | No serious adverse event |
Radwan et al.,2023 | 20 | Mild headaches (N = 4) | 20 | No serious adverse event |
Grecco et al.,2017 | 3 | Tingling (N = 3) | 3 | Tingling (N = 3) |
Grecco et al.,2014b | 10 | Redness and tingling (N = 3) | 10 | Redness and tingling (N = 3) |
Grecco et al.,2023 | 15 | Tingling (N = 12) Redness (N = 15) | 15 | Ringling (N = 10) |
He et al.,2024 | 15 | No serious adverse event | 16 | No serious adverse event |